• Lauren Arcuri

  • Seeing Into the Future

    November 30, 2017

    Spark Therapeutic’s experimental treatment for a hereditary form of blindness called Leber congenital amaurosis (LCA) is close to being available to patients. An advisory committee… Continue Reading »